Product News and Recalls

FDA releases list of meningitis pharmacy customers

The U.S. Food and Drug Administration has released a list of customers of a pharmacy linked with a deadly meningitis outbreak.

According to a story on Patch.com, the list does not include the specific products that the customers received from the New England Compounding Center in Framingham, Mass. The meningitis outbreak is linked to a batch of injectable steroid medication commonly used to treat steroids, which was tainted with a fungus.

Meningitis is an inflammation of the tissue that surrounds the spinal cord and brain. The current outbreak has sickened 317 people and killed 24 in 17 states, according to the federal Centers for Disease Control and Prevention.

As many as 14,000 people may have been infected, the CDC estimates.

The FDA list was based on information provided by NECC. The federal agency has stated that it cannot vouch for its accuracy. It’s organized by state, and includes customer names and addresses.

According to the FDA, patients who believe they received an injection or other product that NECC shipped on or after May 21 should be on the lookout for meningitis symptoms, and contact their health care providers if they have concerns. Symptoms include fever, headache, stiff neck, nausea and vomiting, sensitivity to light and altered mental status.

Lopez McHugh is investigating cases related to this outbreak. If you or a loved one had an injection and were diagnosed with meningitis, you should consult with a Lopez McHugh lawyer for a free consultation.

See the Patch.com article here:

http://framingham.patch.com/articles/fda-releases-list-of-necc-customers

See the FDA list here:

http://www.fda.gov/downloads/Drugs/DrugSafety/FungalMeningitis/UCM325467.pdf